Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
10 May 2023 |
On P&L |
The Company releases the press release related to the first quarter 2023 financial results
|
Download |
|
10 May 2023 |
On P&L |
The Company releases the first quarter 2023 financial results presentation
|
Download |
|
25 Apr 2023 |
On business and financial situation |
ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE)
|
Download |
|
21 Feb 2023 |
On business and financial situation |
The Company releases the full year 2022 financial results presentation.
|
Download |
|
21 Feb 2023 |
On business and financial situation |
The Company releases the press release related to the full year 2022 financial results.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
10 May 2023 |
Announcement of General Shareholders’ Meeting |
ROVI releases the information related to its General Shareholders Meeting
|
Download |
|
10 Apr 2023 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the first quarter of 2023
|
Download |
|
21 Feb 2023 |
Annual Corporate Governance Report |
ROVI releases the 2022 Annual Corporate Governance Report
|
Download |
|
21 Feb 2023 |
Annual Report regarding remuneration of the members of the Board of Directors |
ROVI releases the 2022 annual report regarding remuneration of the members of the Board of Directors
|
Download |
|
16 Feb 2023 |
On business and financial situation |
The Company informs on the evaluation process to obtain marketing authorisation for Risvan® (Risperidone ISM®) in the United States.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
04 Oct 2018 |
Share capital increases and reductions |
Private placement capital increase addressed to institutional investors, excluding preferential subscription rights
|
Download |
|
02 Oct 2018 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the third quarter of 2018
|
Download |
|
24 Sep 2018 |
Others on business performance and financial information |
Updated information on business, financial position and risk factors
|
Download |
|
24 Sep 2018 |
Share capital increases and reductions |
Intention to raise gross proceeds by means of an offer addressed to institutional investors, excluding preferential subscription rights
|
Download |
|
26 Jul 2018 |
Información sobre resultados |
ROVI releases the 2018 first half results presentation
|
Download |
Pages
